🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

📖 Help & Search Guide

Column Icons Legend

💀 Death
🏥 Hospitalized
🚑 Emergency Room
♿ Disability
⚠️ Life Threatening

How to Search

💡 Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "📥 Export CSV" to download filtered data (max 10,000 records)

💡 Frequently Asked Questions (FAQ)

What is this site?

🏥 VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • ✅ Early warning system for potential safety signals
  • ✅ Open and transparent - publicly accessible
  • ✅ Accepts all reports regardless of likelihood of causation
  • ✅ Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • ⚠️ Reports are unverified - not investigated before publication
  • ⚠️ Cannot determine if vaccine caused the event
  • ⚠️ Underreporting - not all adverse events are reported
  • ⚠️ Overreporting - coincidental events may be reported
  • ⚠️ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
🔄 Reset 📥 Export CSV
ID Age Sex State Date ▼ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative 💀 🏥 🚑 ♿ ⚠️
2841514 M 05/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 59MC4
Product preparation issue Product preparation issue
patient was only given the liquid; patient was only given the liquid; This non-serious case was repo... patient was only given the liquid; patient was only given the liquid; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a male patient who received Herpes zoster (Shingrix) (batch number 59MC4, expiry date 10-MAR-2027) for prophylaxis. On 13-MAY-2025, the patient received the 1st dose of Shingrix. On 13-MAY-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patient was only given the liquid) and inappropriate dose of vaccine administered (Verbatim: patient was only given the liquid). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 13-MAY-2025 The healthcare professional stated that on the day of reporting another staff member prepared the dose to be administered to a male patient, and the staff member did not know it was two vials, so the patient was only given the liquid. She confirms this was intended to be the first dose of the series, and this occurred this morning, 13 May 2025. The patient received only adjuvant of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. More
2841515 M FL 05/19/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS

Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure
Suspected vaccination failure; Shingles after finishing series; This serious case was reported by a ... Suspected vaccination failure; Shingles after finishing series; This serious case was reported by a pharmacist via call center representative and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, 1 year after receiving Shingrix and Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles after finishing series). The outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix. The company considered the vaccination failure and shingles to be unrelated to Shingrix and Shingrix. Additional Information: GSK Receipt Date: 13-MAY-2025 On 13th May 2025, a pharmacist called to inform that the patient had completed the Shingrix series back in 2017. He had developed shingles one year later. This case was considered as suspected vaccination failure as details regarding laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: "Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about laboratory confirmation of disease) is considered unrelated to GSK Shingrix. Herpes zoster is an unlisted event which is considered unrelated to GSK Shingrix." More
2841516 F GA 05/19/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 235DZ
Product administered to patient of inappropriate age, Wrong product administered Product administered to patient of inappropriate age, Wrong product administered
A 15 months old female patient received a dose of Boostrix; A 15 months old female patient received ... A 15 months old female patient received a dose of Boostrix; A 15 months old female patient received a dose of Boostrix; A 15 months old female patient received a dose of Boostrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 15-month-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 235DZ, expiry date 10-JAN-2027) for prophylaxis. Co-suspect products included DTPa (DTaP vaccine) for prophylaxis. On an unknown date, the patient received Boostrix and DTaP vaccine. On an unknown date, an unknown time after receiving Boostrix and not applicable after receiving DTaP vaccine, the patient experienced wrong vaccine administered (Verbatim: A 15 months old female patient received a dose of Boostrix), accidental underdose (Verbatim: A 15 months old female patient received a dose of Boostrix) and inappropriate age at vaccine administration (Verbatim: A 15 months old female patient received a dose of Boostrix). The outcome of the wrong vaccine administered, accidental underdose and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 14-MAY-2025 A Medical Assistant called to report that a 15 months old patient received by mistake Boostrix instead of the DTaP vaccine, which led to inappropriate age at vaccine administration, wrong vaccine administered and accidental underdose. It was the 4th dose for the patient because the patient has already 3 previous doses of DTaP. The reporter asked if they had any information regarding this situation. The reporter consented to follow up. More
2841517 80 M 05/19/2025 COVID19
 MODERNA
 041L20A
Myelodysplastic syndrome, Thrombocytopenia Myelodysplastic syndrome, Thrombocytopenia
fluctuating thrombocytopenia (platelet counts between 35,000-60,000/�L); Myelodysplastic Syndromes... fluctuating thrombocytopenia (platelet counts between 35,000-60,000/�L); Myelodysplastic Syndromes (MDS); This spontaneous case was reported by a patient and describes the occurrence of MYELODYSPLASTIC SYNDROME (Myelodysplastic Syndromes (MDS)) and THROMBOCYTOPENIA (fluctuating thrombocytopenia (platelet counts between 35,000-60,000/�L)) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 030M20A) for COVID-19 prophylaxis. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) dosage was changed to 1 dosage form. In September 2024, the patient experienced MYELODYSPLASTIC SYNDROME (Myelodysplastic Syndromes (MDS)) (seriousness criterion medically significant). In January 2025, the patient experienced THROMBOCYTOPENIA (fluctuating thrombocytopenia (platelet counts between 35,000-60,000/�L)) (seriousness criterion medically significant). At the time of the report, MYELODYSPLASTIC SYNDROME (Myelodysplastic Syndromes (MDS)) and THROMBOCYTOPENIA (fluctuating thrombocytopenia (platelet counts between 35,000-60,000/�L)) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Platelet count: platelet counts between 35,000-60,000/�L (low) since Jan-2025. No concomitant medications were reported. The patient was diagnosed with Myelodysplastic Syndromes (MDS) in September 2024, and had been monitoring his health closely, particularly his thrombocytopenia (low platelet counts), which had fluctuated between 35,000 and 60,000/A�L since January 2025. His healthcare team guided his ongoing treatment decisions, which included exploring RUNX1-targeted clinical trials due to his genetic mutations (PHF6, BCOR, RUNX1). The patient was exploring all possible factors that might had influenced the patient's condition, including the vaccines that the patient received in 2021.; Reporter's Comments: The patient's genetic mutations (PHF6, BCOR, RUNX1) remain as confounders for the events. The benefit-risk relationship of the product is not affected by this report. More
2841518 46 F NJ 05/19/2025 COVID19
 MODERNA
Condition aggravated, Electrocardiogram ambulatory, Myocarditis Condition aggravated, Electrocardiogram ambulatory, Myocarditis
She developed myocarditis; She developed myocarditis. And she still has it. In fact, now it's g... She developed myocarditis; She developed myocarditis. And she still has it. In fact, now it's getting worse; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MYOCARDITIS (She developed myocarditis) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (She developed myocarditis) (seriousness criterion medically significant) and CONDITION AGGRAVATED (She developed myocarditis. And she still has it. In fact, now it's getting worse). At the time of the report, MYOCARDITIS (She developed myocarditis) had not resolved and CONDITION AGGRAVATED (She developed myocarditis. And she still has it. In fact, now it's getting worse) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram ambulatory: myocarditis came back. No vaccines within the past 4 weeks prior to the Moderna vaccine was reported. No concomitant medications were reported. The reporter inquired about methods for removing the COVID spike protein from the body of someone who had received the Moderna COVID vaccine. The reporter and her daughter had received three doses of the Moderna Covid vaccine, including two primary doses and a booster. The patient developed myocarditis and continued to suffer from the condition for three years. It was reported that the patient had never contracted COVID and was dealing with myocarditis which was worsening. Despite being on inflammatory and anti-inflammatory medications, patient's health was deteriorating, as confirmed by a Holter monitor test, which detected new complications. HCP recommended implanting a loop recorder in her chest. It was reported that patient had no cardiac blockages and was otherwise a healthy and slim woman. It was suggested that the vaccine was responsible for her condition. It was reported that for some people, the spike protein naturally dissipates, but for others, it remains and causes ongoing health issues. She reported that doctors had not devised a treatment plan, and she criticized claims that myocarditis primarily affects men aged 19 to 30, asserting that individuals up to the age of 80 had reported similar issues. She sought answers regarding the removal of the spike protein. She confirmed that neither her daughter nor son-in-law had experienced any other side effects. She reported that Moderna had known that myocarditis could result from the vaccine but failed to disclose it properly. She mentioned clinical trials she saw on TV, saying that myocarditis had been documented but was reportedly considered a temporary issue in young people. The reporter reiterated that Moderna had known that myocarditis would result from it. The reporter questioned whether the company had a plan to treat vaccine-induced myocarditis, and she also found it strange that both her daughter and her husband had developed the condition. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2025-786302 (E2B Linked Report).; Reporter's Comments: The benefit -risk relationship of product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-786302:same reporter different patient More
2841519 66 F 05/19/2025 FLU3
 SEQIRUS, INC.
 No batch number
Injection site paraesthesia, Injection site warmth Injection site paraesthesia, Injection site warmth
Within about an hour after shot area around arm began to feel hot, prickly on fire; This spontaneous... Within about an hour after shot area around arm began to feel hot, prickly on fire; This spontaneous case, initially received on 09-Apr-2025, was reported by a non health professional and concerns an elderly female patient. Past medical history included Latex allergy. Historical vaccine include: Comirnaty((2023-2024), syringe, 0.3 ml, right arm) Concomitant medication: refer to appropriate report section. Administration of company suspect drug: On 23-Jul-2024, the patient received Fluad (TIV) for Indication flu vaccine, Dose regimen: 0.5 ml, Route of administration: Intramuscular, Anatomical location: Left arm, Lot number: No batch number available, and would be requested on follow-up. No additional suspect drugs. Adverse reactions/events and outcomes: On 23-Jul-2024, the patient experienced Within about an hour after shot area around arm began to feel hot, prickly on fire (outcome: Recovered / Resolved). It was reported that flu shot was given in left arm and Covid shot, Comirnaty was injected in right arm. Within 2 days right arm had a similar reaction but much less than the flu shot. Patient had never had a reaction to either the flu or covid shots in the past and these were very much like latex reactions and therefore it started my search for ingredients. The pharmacy swore that they did not use latex in gloves, bandages and the only place a latex could have been found would have been something that would cause a latex-like reaction, but it couldn't be proved as many people have a latex allergy. Fluad (TIV) action taken: Not Applicable Treatment medication: Triamcinolone Reporter's assessment: The reporter did not provide a seriousness or causality assessment.; Reporter's Comments: The causality of events was assessed related to the administration of Fluad (TIV) More
2841520 VA 05/19/2025 UNK
 UNKNOWN MANUFACTURER
 No batch number
Respiratory distress Respiratory distress
Respiratory distress; This spontaneous case initially received on 10-Apr-2025, was reported by a hea... Respiratory distress; This spontaneous case initially received on 10-Apr-2025, was reported by a health professional and concerns a patient of unknown age/gender. At the time of the event the patient had alpha gal, other allergies. Administration of company suspect drug: On an unknown date, the patient received Flucelvax (TIV) for an Indication not reported., Dose regimen, route of administration, and anatomical location: Not Reported, Lot number: No batch number available and would be requested upon follow-up. No additional suspect drugs. Adverse reactions/events and outcomes: On an unknown date, the patient experienced Respiratory distress (Medically Significant, outcome: Not Reported). Case was upgraded to serious upon company assessment of the reported event clinical significance Reporter shared that a patient received Flucelvax and had respiratory distress. The reporter told that the patient had alpha gal and other allergies. Flucelvax (TIV) action taken: Not Applicable Reporter's assessment: The reporter did not provide the seriousness and causality assessment of the event Respiratory distress.; Reporter's Comments: Causality: Due to the spontaneous nature of the case, events considered related for reporting purposes. There is insufficient information regarding the event for a meaningful causal assessment (event onset date, temporality, unclear etiology, relevant medical history). Of note, underlying condition of alpha gal can be considered as contributing factor. More
2841521 F MA 05/19/2025 FLU3
 SEQIRUS, INC.
 946615
Hypersensitivity Hypersensitivity
Ingredients of vaccine following possible allergic reaction; This spontaneous case, initially receiv... Ingredients of vaccine following possible allergic reaction; This spontaneous case, initially received on 22-Apr-2025, was reported by a non health professional and concerns a female patient. Administration of company suspect drug: On an unknown date, the patient received Flucelvax (TIV) for Influenza prophylaxis, dose: not reported, route of administration: not reported, anatomical location: not reported, Lot number: 946615. No additional suspect drugs. Adverse reactions/events and outcomes: On an unknown date, the patient experienced Ingredients of vaccine following possible allergic reaction (outcome: Not Reported). Consumer called to inquire about ingredients of vaccine following possible allergic reaction after her daughter was given the vaccine in October, specific type of reaction not provided. Covid vaccine was also mentioned as a suspected source of allergy, although product information was not specified. Caller refused to provide patient information. Flucelvax (TIV) action taken: Not Applicable Reporter's assessment: The reporter considered the events Ingredients of vaccine following possible allergic reaction related to the administration of Flucelvax (TIV) and seriousness was not provided.; Reporter's Comments: Event is related More
2841522 M 05/19/2025 COVID19
UNK
 PFIZER\BIONTECH
UNKNOWN MANUFACTURER
 LM2223
388466
Bell's palsy, Blood glucose increased, Headache, Muscle twitching, Vaccinat... Bell's palsy, Blood glucose increased, Headache, Muscle twitching, Vaccination site atrophy; Bell's palsy, Blood glucose increased, Headache, Muscle twitching, Vaccination site atrophy More
Bell's palsy / his face was drooping on his right side; He was getting some twitching in the mu... Bell's palsy / his face was drooping on his right side; He was getting some twitching in the muscles in his face and neck; He also had a headache behind his right eat; Has an atrophy of his right arm bicep and he got the his shots in the left arm; His blood glucose went up; This spontaneous case, initially received on 28-Apr-2025, was reported by a non health professional and concerns a male patient. Weight: 68.49 kg; Height: 165 cm Past medical history included Pacemaker, Bladder cancer and surgery, Bladder cancer and surgery. At the time of the event the patient had Gout, High cholesterol. Concomitant medication: refer to appropriate report section. Administration of company suspect drug: On 29-Aug-2024, the patient received Fluad (TIV) for Routine vaccination, Dose regimen: 0.5 ml, Route of administration: Not reported, Anatomical location: Left arm. Lot number: 388466. Non-company suspect drugs: Comirnaty (Tozinameran), Indication: Routine vaccination. Adverse reactions/events and outcomes: On 03-Sep-2024, the patient experienced Bell's palsy / his face was drooping on his right side (Medically Significant, outcome: Recovering / Resolving). Associated symptoms included: He was getting some twitching in the muscles in his face and neck, He also had a headache behind his right eat. Case was upgraded to serious upon company assessment of the reported events clinical significance. On Sep-2024, the patient experienced Has an atrophy of his right arm bicep and he got the his shots in the left arm (outcome: Recovering / Resolving), His blood glucose went up (outcome: Recovering / Resolving). Caller was a consumer calling about the medication Covid-19 2024-2025 and reported that at the same time that his pharmacist administered the covid vaccine he also got the annual flu shot. The flu shot was the Fluad adjuvanted 65 plus. He has had all of the covid vaccines, initial, the next set, and all 7 or 8 of them, stated that they were all the same vaccines. Up through the vaccine that he had in 09-Sep-2023 and then 28-Mar-2024, prior to the one he just got he has had no reaction or anything. On 29-Aug-2024, 5 days later in the beginning of Sep-2024 he developed Bell's palsy. In looking in the literature, the biopharma literature, there may be some studies from 2022, a small group of people may develop Bell's palsy after receiving the Covid vaccines. They might have seen some cases, but since he had no experience with Covid vaccines prior, it was rather suspect that the vaccine he received in Aug-2024 caused him to get bell's palsy. It could be stress or something else. On 03-Sep-2024, he was having lunch with his daughter and when he took off his N95 mask, his daughter said his face was drooping on his right side and they went to the Emergency Room and they ruled out stroke and told him he had Bell's palsy. They normally give Acyclovir, and they gave him that for a period of time and also gave him prednisone, a corticosteroid. After researching if, take a corticosteroid within 2 weeks after a Covid vaccine, it was said that the vaccine may not be as effective. When he went to pick up his prescriptions on Friday, they offered him to take the same covid vaccine that he had in Aug-2024, a repeat of the same dose. He told them he had Bell's palsy and the told him to report it to the manufacturer. Also told him to speak to his physician about getting another dose. They did not show anything that it causes bell's palsy, but he could be a rare case. Online said that there may be a mild reaction that makes it less effective if corticosteroids are taken within 2 weeks of receiving the covid vaccine. Asked if this was true. He still has a little droop in his smile, but not much. He was getting some twitching in the muscles in his face and neck, like his muscles are trying to wake up. Also reported that he can wiggle his ears. Initially he was not able to wiggle the right side ear, he could hardly move it to where you could see it wiggle. He also had a headache behind his right ear, but was not bad, just a little bit. Treated with Tylenol that seemed to help. Overtime he can now wiggle his ear. Dose site: Has an atrophy of his right arm bicep and he got the his shots in the left arm. Testing: They did routine testing and everything was normal, because of the shock of it, his blood glucose went up, but went back down to normal. He said that there is no interaction between the flu shot and corticosteroid. Reporter got the vaccine back at the end of 29-Aug-2024 at the same with the flu shot. 5 days after got the Covid vaccine, patient came down with Bell's Palsy and went to the ER they ruled out stroke and everything else and they said it was Bell's Palsy. So they prescribed Acyclovir for a therapy for adult palsy. And also for the first 5 days, they prescribed Prednisone which is a corticosteroid. Patient asked if there was any interference that the Prednisone would have with getting the Pfizer vaccine. Patient did not start to use the Prednisone until the 4-Sep. Only took it for 5 days and the dose was 20mg 3 times a day, total dose for each of the 5 days was 60mg. Prednisone not starting on Tuesday , the 3rd, 4th, 5th, 6th, 7th and the 8th and stopped it after that. Fluad (TIV) action taken: Not Applicable Treatment medication: Acyclovir, Prednisone, Tylenol Reporter's assessment: The reporter considered the event as non-serious and did not provide the causality of the events.; Reporter's Comments: Causality: Due to the spontaneous nature of the case, it is considered related for reporting purposes. Related considering plausible temporality (1 month after receiving vaccine). Past medical history of Pacemaker, Bladder cancer and surgery, Bladder cancer and surgery.Underlying conditions of Gout, High cholesterol provide plausible etiology in occurence of events. Related for event vaccination site atrophy considering anatomical proximity. Brighton collaboration criteria is assessed as level 4 due to insufficient information provided. More
2841528 F NC 05/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 FJ9A7
Product preparation issue Product preparation issue
received the diluent without the adjuvant; received the diluent without the adjuvant; This non-serio... received the diluent without the adjuvant; received the diluent without the adjuvant; This non-serious case was reported by a physician via sales rep and described the occurrence of inappropriate preparation of medication in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number FJ9A7, expiry date 16-JUL-2026) for prophylaxis. Concurrent medical conditions included cholesterol. Concomitant products included atorvastatin calcium (Lipitor). On 02-MAY-2025, the patient received the 1st dose of Shingrix (left deltoid). On 02-MAY-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: received the diluent without the adjuvant) and inappropriate dose of vaccine administered (Verbatim: received the diluent without the adjuvant). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 09-MAY-2025 The physician reported that the patient received the diluent without the adjuvant, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. More
2841529 05/19/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Malaise, Nausea, Pain in extremity Malaise, Nausea, Pain in extremity
The first shot made me really sick; nauseous; arm hurts; This non-serious case was reported by a con... The first shot made me really sick; nauseous; arm hurts; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: The first shot made me really sick), nausea (Verbatim: nauseous) and pain in arm (Verbatim: arm hurts). The outcome of the sickness, nausea and pain in arm were not reported. It was unknown if the reporter considered the sickness, nausea and pain in arm to be related to Shingles vaccine. It was unknown if the company considered the sickness, nausea and pain in arm to be related to Shingles vaccine. Linked case(s) involving the same patient: US2025AMR058760 Additional Information: GSK Receipt Date : 10-MAY-2025 This case was reported by a patient via interactive digital media. The first shot made him/her really sick. Arm hurts and a lil nauseous but not as bad as the first one by far. For tolerance of second shot refer case US2025AMR058760.; Sender's Comments: US-GSK-US2025AMR058760:same patient, 1st dose case More
2841530 CA 05/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 9L944
Product preparation issue Product preparation issue
had received only the adjuvant portion of Shingrix; received only the adjuvant portion; This non-ser... had received only the adjuvant portion of Shingrix; received only the adjuvant portion; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) (batch number 9L944, expiry date 30-MAR-2027) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: had received only the adjuvant portion of Shingrix) and inappropriate dose of vaccine administered (Verbatim: received only the adjuvant portion). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 09-MAY-2025 Other HCP reported that there were 5 patients involved in an incident where they didn't know which of them had received only the adjuvant portion of Shingrix. Also, reporter mentioned that they were investigating this incident, but that it may be possible that they readministered the doses to the patients, leading to a potential 3rd dose administered to any of these patients, as some of them had already received the 1st dose of Shingrix. The patient received only adjuvant of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.; Sender's Comments: US-GSK-US2025057630:SAME REPORTER US-GSK-US2025057623:same reporter More
2841531 F MT 05/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Incomplete course of vaccination Incomplete course of vaccination
received 1 out of 2 of the shots back in 2020, and never got the 2nd one; This non-serious case was ... received 1 out of 2 of the shots back in 2020, and never got the 2nd one; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on 02 November 2020). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: received 1 out of 2 of the shots back in 2020, and never got the 2nd one). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 09-MAY-2025 The registered pharmacist reported that one of the patients received 1 out of 2 of the Shingrix shots back in 2020 on 02nd November 2020, and she never got the 2nd one which led to incomplete course of vaccination. The Vaccine Administration Facility is the same as Primary Reporter. More
2841586 37 F 05/19/2025 ANTH
ANTH
ANTH
 EMERGENT BIOSOLUTIONS
EMERGENT BIOSOLUTIONS
EMERGENT BIOSOLUTIONS
 300213A
300213A
300213A
Asthenia, Axillary pain, Injection site erythema, Injection site pruritus, Injec... Asthenia, Axillary pain, Injection site erythema, Injection site pruritus, Injection site reaction; Injection site swelling, Injection site warmth, Pain in extremity, Skin tightness, Skin warm; Sleep disorder More
Tightness around injection site while trying to sleep approx 12 hours after administration. Pt repor... Tightness around injection site while trying to sleep approx 12 hours after administration. Pt reports warm to touch with pain also under the arm. Pt was given Tylenol 500mg the next morning and then again 6 hours later, pt reports during the time of OTC medication pt reports reduced pain to the area, but reports pain after meds have worn off. Pt reports waking up to pain to the Left arm around the middle of the night and pain was located to the same areas as before. Friday morning pt reported that injection site was red and warm to touch from deltoid to bicep and reports swelling to the area as well, pt was given additional medication doxycycline and pt reports after taking the doxy the swelling had reduced. Pt reports while at the gym they have decreased strength during workouts however only to the left arm. Pt reports receiving Motrin and Tylenol for the strength symptoms and pts reports itching around the injection site. More
2841587 81 F PA 05/19/2025 COVID19
 MODERNA
 7654321
Chills, Headache, Influenza like illness, Pyrexia Chills, Headache, Influenza like illness, Pyrexia
Systemic: Chills-Medium, Systemic: Fever-Medium, Systemic: Flu-like symptoms-Medium, Systemic: Heada... Systemic: Chills-Medium, Systemic: Fever-Medium, Systemic: Flu-like symptoms-Medium, Systemic: Headache-Medium More
2841588 69 M TN 05/19/2025 COVID19
 MODERNA
 8080473
Pain, Pneumonia, Respiratory disorder Pain, Pneumonia, Respiratory disorder
Systemic: Body Aches Generalized-Medium, Systemic: Upper Respiratory, breathing, "pneumonia&quo... Systemic: Body Aches Generalized-Medium, Systemic: Upper Respiratory, breathing, "pneumonia"-Medium More
2841589 69 F TN 05/19/2025 COVID19
 MODERNA
 808473
Dyspnoea, Pain, Pneumonia Dyspnoea, Pain, Pneumonia
Systemic: Body Aches Generalized-Medium, Systemic: Difficulty breathing, "pneumonia"-Mediu... Systemic: Body Aches Generalized-Medium, Systemic: Difficulty breathing, "pneumonia"-Medium More
2841590 22 F MA 05/19/2025 HPV9
 MERCK & CO. INC.
 y012776
Arthralgia, Injection site pain Arthralgia, Injection site pain
Site: Pain at Injection Site-Medium, Systemic: pain/discomfort around shoulder area-Medium Site: Pain at Injection Site-Medium, Systemic: pain/discomfort around shoulder area-Medium
2841591 81 F MN 05/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 3j2s2
Injection site abscess, Injection site pain, Injection site swelling, Nausea, Ra... Injection site abscess, Injection site pain, Injection site swelling, Nausea, Rash More
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injec... Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Nausea-Medium More
2841592 50 F SC 05/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 x5742
Injection site swelling Injection site swelling
Site: Swelling at Injection Site-Severe, Additional Details: swelling happened 1 day after immunizat... Site: Swelling at Injection Site-Severe, Additional Details: swelling happened 1 day after immunization More
2841593 65 M MD 05/19/2025 COVID19
 MODERNA
 3042646
COVID-19 COVID-19
Systemic: Patient says he got infected with COVID-19 in October 2024.-Medium, Additional Details: Pa... Systemic: Patient says he got infected with COVID-19 in October 2024.-Medium, Additional Details: Patient says he got infected with COVID-19 in October 2024. More
2841594 74 F CA 05/19/2025 COVID19
COVID19
 MODERNA
MODERNA
 3042560
3042560
Chills, Injection site pain, Nausea, Syncope, Unresponsive to stimuli; Vomiting Chills, Injection site pain, Nausea, Syncope, Unresponsive to stimuli; Vomiting
Site: Pain at Injection Site-Medium, Systemic: Chills-Medium, Systemic: Fainting / Unresponsive-Medi... Site: Pain at Injection Site-Medium, Systemic: Chills-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Medium More
2841596 59 F CT 05/19/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 EB499
Flushing, Hyperhidrosis, Injection site swelling, Pyrexia Flushing, Hyperhidrosis, Injection site swelling, Pyrexia
Site: Swelling at Injection Site-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium Site: Swelling at Injection Site-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium
2841597 68 F FL 05/19/2025 COVID19
 MODERNA
 3042388
Injection site pruritus, Malaise, Pyrexia Injection site pruritus, Malaise, Pyrexia
Site: Itching at Injection Site-Medium, Systemic: Fever-Mild, Systemic: Patient stated she felt sick... Site: Itching at Injection Site-Medium, Systemic: Fever-Mild, Systemic: Patient stated she felt sick and had a fever of 101-Medium, Additional Details: Patient did not complain of site reactions, system would not let me continue until I chose one. More
2841598 22 F CT 05/19/2025 HEP
 DYNAVAX TECHNOLOGIES CORPORATION
 945663
Dizziness, Loss of consciousness, Nausea, Syncope, Unresponsive to stimuli Dizziness, Loss of consciousness, Nausea, Syncope, Unresponsive to stimuli
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Naus... Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Nausea-Medium, Additional Details: Patient recieved a HepB shot and lost conciousness about a minute after receiving the vaccination. Patient was caught by vaccinator and regained concisiosness in about 30 seconds. We immediately called 911. Patient did not appear to hit her head when falling. She did seem to jerk slightly while passed out. EMTs arrived and our assessing patient. More
2841599 50 F CA 05/19/2025 PNC21
 MERCK & CO. INC.
 y019158
Injection site erythema, Injection site pruritus, Injection site swelling Injection site erythema, Injection site pruritus, Injection site swelling
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at In... Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium More
2841601 75 M MD 05/19/2025 COVID19
 MODERNA
 3043153
Brain stem stroke, Fatigue, Lethargy, Pollakiuria Brain stem stroke, Fatigue, Lethargy, Pollakiuria
Systemic: Exhaustion / Lethargy-Medium, Systemic: Urinary frequency-Medium, Systemic: Stroke-Severe,... Systemic: Exhaustion / Lethargy-Medium, Systemic: Urinary frequency-Medium, Systemic: Stroke-Severe, Additional Details: Pt stayed overnight in hospital and then 10 days in rehab recovering. Pt states that stroke was in lower left Pons., Other Vaccines: VaccineTypeBrand: Fluzone High-Dose; Manufacturer: Sanofi-Pasteur; LotNumber: U8489DA; Route: Intramuscular; BodySite: Right Arm; Dose: 1; VaxDate: 09/13/2024 More
✓
2841602 63 F CT 05/19/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 EC2R9
Joint injury Joint injury
Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)- Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
✓
2841603 80 F NV 05/19/2025 COVID19
 MODERNA
 3042560
Headache, Influenza like illness, Pain Headache, Influenza like illness, Pain
Systemic: Body Aches Generalized-Medium, Systemic: Headache-Medium, Additional Details: "Flu-li... Systemic: Body Aches Generalized-Medium, Systemic: Headache-Medium, Additional Details: "Flu-like symptoms", Other Vaccines: VaccineTypeBrand: Influenza FLUAD TRIVALENT; Manufacturer: FLUAD; LotNumber: 388494; Route: IM; BodySite: Left arm; Dose: 1; VaxDate: 09/24/2024 More
2841604 83 F CA 05/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 33fd3
Injection site pain Injection site pain
Site: Pain at Injection Site-Mild, Additional Details: Patient reports that the injection site hurt ... Site: Pain at Injection Site-Mild, Additional Details: Patient reports that the injection site hurt for 3 days after receiving the shingles vaccine. She said that she hasn't experienced this with any other vaccine but the pain was mild. Her arm no longer hurts unless she presses the area. More
2841605 69 M CA 05/19/2025 COVID19
 MODERNA
 8080750
Fatigue, Lethargy, Migraine, Nasopharyngitis Fatigue, Lethargy, Migraine, Nasopharyngitis
Systemic: Exhaustion / Lethargy-Mild, Additional Details: Patient stated that he always gets reactio... Systemic: Exhaustion / Lethargy-Mild, Additional Details: Patient stated that he always gets reactions like the possible side effects (Mild Cold symptoms- Migraines and extreme fatigue) More
2841606 65 F NC 05/19/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 9pm54
Tachycardia Tachycardia
Systemic: Tachycardia-Mild, Additional Details: She said it made her heart race for 1.5 hours and th... Systemic: Tachycardia-Mild, Additional Details: She said it made her heart race for 1.5 hours and then went away on its own. More
2841607 27 F CA 05/19/2025 MMR
 GLAXOSMITHKLINE BIOLOGICALS
 a2b72
Dizziness, Fall, Syncope, Unresponsive to stimuli Dizziness, Fall, Syncope, Unresponsive to stimuli
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details... Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: 5/14/25: Immediately after recieving the priorix, pt fainted and fell to floor. She woke up right away. Mentally alert. Pt stated she had not eaten much today and was dehyrated. Pt was given water and observed for 30 mins. Monitored Blood pressue 3X (bp:98/76 80 @3:56p, bp106/80 83 @4:05p, bp 104/80 83 at 4:17p). pt was counseled on side effects, instruct to go to er/urgent care if condition worsen, stay hyrated, let pcp know what had happened. pt left pharmacy alert and was fine., Other Vaccines: VaccineTypeBrand: gardasil; Manufacturer: merck; LotNumber: y015180; Route: im; BodySite: right arm; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: varivax; Manufacturer: merck; LotNumber: y017063; Route: subcutaneous; BodySite: left arm; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: heplisav b; Manufacturer: dynavax; LotNumber: 946062; Route: im; BodySite: left arm; Dose: ; VaxDate: UNKNOWN More
2841608 71 F CA 05/19/2025 COVID19
 MODERNA
 3042646
Erythema, Injection site erythema, Injection site swelling, Peripheral swelling Erythema, Injection site erythema, Injection site swelling, Peripheral swelling
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details:... Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Patient reports arm was really red and swollen for several days; went back to pharmacy and was advised to f/u with doctor - event did result in patient needing to visit the doctor - flu shot was also administered at the same time, Other Vaccines: VaccineTypeBrand: Fluzone High-Dose Triv; Manufacturer: Sanofi-Pasteur; LotNumber: UT8454CA; Route: IM; BodySite: Left Arm; Dose: 1; VaxDate: 08/31/2024 More
2841609 64 F CA 05/19/2025 COVID19
COVID19
 MODERNA
MODERNA
 3042558
3042558
Chills, Fatigue, Headache, Influenza like illness, Lethargy; Pain Chills, Fatigue, Headache, Influenza like illness, Lethargy; Pain
Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Me... Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Headache-Medium, Additional Details: Patient received all 3 vaccines together and experienced flu-like symptoms., Other Vaccines: VaccineTypeBrand: Arexvy; Manufacturer: ; LotNumber: ; Route: ; BodySite: ; Dose: ; VaxDate: UNKNOWN, VaccineTypeBrand: Flubok 2024-2025; Manufacturer: ; LotNumber: ; Route: ; BodySite: ; Dose: ; VaxDate: UNKNOWN More
2841610 52 M MA 05/19/2025 SMALLMNK
 BAVARIAN NORDIC
 96868
Injection site erythema, Injection site swelling Injection site erythema, Injection site swelling
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
2841611 66 M TX 05/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 55th4
Fatigue, Influenza like illness, Lethargy Fatigue, Influenza like illness, Lethargy
Systemic: Exhaustion / Lethargy-Severe, Additional Details: bad flu like symptoms , Other Vaccines:... Systemic: Exhaustion / Lethargy-Severe, Additional Details: bad flu like symptoms , Other Vaccines: VaccineTypeBrand: Arexvy RSV; Manufacturer: ; LotNumber: 9sb34; Route: IM; BodySite: LA; Dose: ; VaxDate: 04/13/2025, VaccineTypeBrand: Boostrix Tdap; Manufacturer: ; LotNumber: 39LB7; Route: IM; BodySite: LA; Dose: ; VaxDate: 04/13/2025 More
2841612 78 F TX 05/19/2025 COVID19
 PFIZER\BIONTECH
 LM2224
Nervous system disorder, Tinnitus Nervous system disorder, Tinnitus
Systemic: Neurological Disorder (diagnosed by MD)-Medium, Systemic: Tinnitus-Medium, Other Vaccines:... Systemic: Neurological Disorder (diagnosed by MD)-Medium, Systemic: Tinnitus-Medium, Other Vaccines: VaccineTypeBrand: Fluad Trivalent - Flu; Manufacturer: Seqirus, Inc.; LotNumber: 388497; Route: IM; BodySite: Left Deltoid; Dose: 1; VaxDate: 12/16/2024 More
2841613 63 F NY 05/19/2025 PNC20
 PFIZER\WYETH
 MF0416
Chills, Injection site pain, Pyrexia Chills, Injection site pain, Pyrexia
Site: Pain at Injection Site-Severe, Systemic: Chills-Severe, Systemic: Fever-Severe, Other Vaccines... Site: Pain at Injection Site-Severe, Systemic: Chills-Severe, Systemic: Fever-Severe, Other Vaccines: VaccineTypeBrand: SHINGRIX; Manufacturer: GLAXOSMITHKLINE; LotNumber: 55TH4; Route: IM; BodySite: LEFT DELTOID; Dose: 1; VaxDate: 05/09/2025, VaccineTypeBrand: BOOSTRIX TDAP; Manufacturer: GLAXOSMITHKLINE; LotNumber: PG3RP; Route: IM; BodySite: LELT DELTOID; Dose: 1; VaxDate: 05/09/2025 More
2841614 71 F IL 05/19/2025 COVID19
 MODERNA
 3043334
Headache, Pain, Pyrexia Headache, Pain, Pyrexia
Systemic: Body Aches Generalized-Medium, Systemic: Fever-Medium, Systemic: Headache-Medium Systemic: Body Aches Generalized-Medium, Systemic: Fever-Medium, Systemic: Headache-Medium
2841615 66 F VA 05/19/2025 COVID19
 MODERNA
 3043157
Chills, Fatigue, Lethargy Chills, Fatigue, Lethargy
Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium
2841616 66 F VA 05/19/2025 COVID19
COVID19
 MODERNA
MODERNA
 AU3920B
AU3920B
Breast cancer female, COVID-19, Cough, Fatigue, Headache; Lethargy, Tachycardia Breast cancer female, COVID-19, Cough, Fatigue, Headache; Lethargy, Tachycardia
Systemic: Exhaustion / Lethargy-Medium, Systemic: Cough, Breast cancer diagnosis-Medium, Systemic: H... Systemic: Exhaustion / Lethargy-Medium, Systemic: Cough, Breast cancer diagnosis-Medium, Systemic: Headache-Medium, Systemic: Tachycardia-Medium, Additional Details: Patient says she was diagnosed with Breast cancer after her COVID vaccine. Patient also says she was infected with COVID-19 two months (around April 2024) after her Moderna 2023-2024 covid vaccine that was given on 02/26/2024. More
2841617 44 F MO 05/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 9L944
Injection site erythema, Rash, Skin warm Injection site erythema, Rash, Skin warm
Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-M... Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Rash on arms 4 inches-Mild, Additional Details: Rash on arm was 4 inches and left arm was warm to the touch. More
2841618 62 F TX 05/19/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 EB499
Injection site erythema, Injection site pain, Injection site swelling Injection site erythema, Injection site pain, Injection site swelling
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection... Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: Pain at arm subsided but returned after few days. She said this happened before to tdap vaccine. if doesn't resolve in next few days, report to md More
2841619 70 M MI 05/19/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 9L944
Hypoaesthesia, Imaging procedure abnormal, Paraesthesia Hypoaesthesia, Imaging procedure abnormal, Paraesthesia
After administration patient reported tingling and numbness. Unknown exactly how fast for symptoms t... After administration patient reported tingling and numbness. Unknown exactly how fast for symptoms to start. Symptoms have mostly resolved but some tingling in finger tips are still reported. More
2841620 75 F TX 05/19/2025 HEPAB
PNC21
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 P2443
Y019158
Erythema, Musculoskeletal pain, Pain in extremity, Pyrexia; Erythema, Musculoske... Erythema, Musculoskeletal pain, Pain in extremity, Pyrexia; Erythema, Musculoskeletal pain, Pain in extremity, Pyrexia More
Patient called on 5/14/25 saying that she had fever, redness in arm, arm pain into shoulder blade; s... Patient called on 5/14/25 saying that she had fever, redness in arm, arm pain into shoulder blade; she said that she had taken some tylenol; I told her if doesn't resolve symptoms to contact her primary care physician More
2841622 30 F OH 05/19/2025 COVID19
MMR
VARCEL
 PFIZER\BIONTECH
MERCK & CO. INC.
MERCK & CO. INC.
 LP1776
Y014094
y014181
Injection site mass, Injection site pain; Injection site mass, Injection site pa... Injection site mass, Injection site pain; Injection site mass, Injection site pain; Injection site mass, Injection site pain More
painful, palpable lump at injection site of MMR II in Right arm painful, palpable lump at injection site of MMR II in Right arm
2841623 79 M WV 05/19/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 5K4X4
Injection site rash, Rash, Tenderness Injection site rash, Rash, Tenderness
DEVELOPED RASH ON BOTH CHEEKS OVER TO THE EAR, SOMEWHAT SORE TO TOUCH, RASH ON LEFT MORE THAN RIGHT... DEVELOPED RASH ON BOTH CHEEKS OVER TO THE EAR, SOMEWHAT SORE TO TOUCH, RASH ON LEFT MORE THAN RIGHT SIDE. NO REACTION/ RASH AT INJECTION SITE. ONLY ON FACE. DEVELOPED BY 5/17/25 MORNING AND SEEMED WORSE SATURDAY AFTERNOON. PATIENT REPORTS RASH GETTING BETTER (5/19/25). PATIENT MAY GO TO DERMATOLOGIST More
2841624 39 F IN 05/19/2025 TDAP
 SANOFI PASTEUR
 u8232aa
Erythema, Inflammation, Lymphadenopathy, Muscle mass Erythema, Inflammation, Lymphadenopathy, Muscle mass
Knot in muscle, vasculature surrounding appears inflamed/redness developed, lymph node involvement a... Knot in muscle, vasculature surrounding appears inflamed/redness developed, lymph node involvement and accumulation. More
2841625 16 F WI 05/19/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 49M9N
Hypoaesthesia, Pain in extremity Hypoaesthesia, Pain in extremity
She has a sore arm that cannot feel her hand. It feels numb and dead like She has a sore arm that cannot feel her hand. It feels numb and dead like
📋 Privacy Policy & Data Disclaimer